Printer Friendly
The Free Library
19,122,083 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Collaboration with Samaritan Pharmaceuticals, SIS Foundation, and Harvest Biotech Foundation in Africa to Provide Free Drugs to African Children with AIDS.


Business Editors/Health/Medical Writers

LAS VEGAS--(BUSINESS WIRE)--Sept. 12, 2003

Samaritan Pharmaceuticals Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:SPHC), its philanthropic arm, the Samaritan Innovative Science Foundation (SISF SISF Superlattice Intrinsic Stacking Fault ), and A Harvest Biotech Foundation International, Africa (AHBFI) today announced the formation of a collaboration to provide free drugs to children with AIDS in Africa.

Why It Matters

UNICEF UNICEF (y`nĭsĕf'), the United Nations Children's Fund, an affiliated agency of the United Nations.  noted that while Africa accounts for only 12 per cent of the world's population, it claims 43 per cent of the world's child deaths, 50 per cent of maternal deaths in childbirth, 70 per cent of people living with HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome , and a staggering 90 percent of all children orphaned by AIDS.

Strategic Links to Africa

Dr. Wambugu, Executive Director of AHBFI is networked with numerous organizations, one being, New Partnerships for Africa Development (NEPAD NEPAD New Partnership for Africa's Development ). Dr. Wambugu, as a passionate believer in service to humankind, also serves on the board of the Bill & Melinda Gates Melinda French Gates (born Melinda Ann French on August 15, 1964) is a former unit manager for several Microsoft products: Publisher, Microsoft Bob, Encarta, and Expedia. In 1994, she married Bill Gates, founder, chairman, and former chief software architect of Microsoft.  Foundation: Global Health Challenge and the United Nations: Hunger Task Force, providing the collaboration with an incredible strategic link to Africa.

Dr. Janet Greeson, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Samaritan Pharmaceuticals and Chairman and Founder of SIS Foundation stated, "Dr. Wambugu is awesome. Immediately, you sense her passion for Africa, and it becomes contagious."

Humanitarian Purpose

The purpose of the collaboration is to concentrate on alleviating the life-and-death challenges facing children and adults with AIDS in Africa. Samaritan's HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  drug has proved promising, safe and effective through proof of concept Phase II clinical human trials. Samaritan hopes to be able to offer this drug, upon FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 approval, at a very low cost to suffering patients.

SIS Foundation Humanitarian Plan

SISF proposes to work with Kenya, AHBFI Africa, WHO, the UN, IntegriHeatlh, and NBC NBC
 in full National Broadcasting Co.

Major U.S. commercial broadcasting company. It was formed in 1926 by RCA Corp., General Electric Co. (GE), and Westinghouse and was the first U.S. company to operate a broadcast network.
 Africa Ltd. to conduct clinical trials first in Kenya and then Johannesburg, Africa. Should these trials prove successful, SISF will continue to work with its collaborative partners to make the drug available to all sub-Saharan Africans with HIV.

About Samaritan Innovative Science Foundation

The SIS Foundation is an independent charitable foundation established by Samaritan Pharmaceuticals, Inc. The Foundation's primary mission is, to demonstrate a Samaritan love of humankind by relieving human misery and suffering. SISF focuses on improving "quality of life" for the underserved and the underprivileged, with a special emphasis on the children of the world with AIDS. http://www.samaritanpharma.org

About A Harvest Biotech Foundation International

"A Harvest" is a non-profit organization incorporated in California, USA. It is registered in Kenya and South Africa as a non-profit organization (NGO NGO
abbr.
nongovernmental organization

Noun 1. NGO - an organization that is not part of the local or state or federal government
nongovernmental organization
) and has operational offices in the three countries. The Foundation is governed by a Board of Directors with local, African and international experience. http://www.ahbfi.org/biotech/

About Samaritan Pharma: "A Little Bridge Can Go a Long Way"

Samaritan Pharmaceuticals, in collaboration with Georgetown University, drives to bridge the gap by effectively translating research from the bench to the bedside. Samaritan strives to accelerate preclinicals, thru human "proof of concept" trials; lessening the time breakthrough drugs, reach suffering Alzheimer's, Cancer, Cardiovascular, and HIV patients. http://www.samaritanpharma.com

Disclaimer

The company disclaims any information that is created by an outside party and endorses only information that is communicated by its press releases, filings and Web site. This news release contains forward-looking statements that reflect management's current beliefs about the potential for its drug candidates, science and technology. However, as with any biopharmaceutical under development, there are significant risks and uncertainties in the process of development and regulatory review. There are no guarantees that products will prove to be commercially successful. For additional information about the factors that affect the company's business, please read the company's latest Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 filed May 15, 2003. The company undertakes no duty to update forward-looking statements.

Contact: Samaritan Innovative Science Foundation, George Weaver 702/735-7001, Fax 702/737-7016, Email Gweaver@samaritanpharma.org. Visit Web site for Samaritan Innovative Science Foundation at www.samaritanpharma.org
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Sep 12, 2003
Words:642
Previous Article:Thomson Announces a Joint Technology Agreement with Panasonic in Digital Broadcast Memory Solution; Unveils Joint End-to-end Workflow Development...
Next Article:Silicon & Software Systems -S3- Announces Availability of Silicon Proven Mixed Signal IP For IEEE802.11 IC Designs.



Related Articles
THE FIGHT FOR THE LIVING.
A CONTINENT AT RISK.
Problems with Current U.S. Policy.
Toward a New Foreign Policy.
All the dying people: HIV/AIDS is causing dramatic losses in Africa, cutting the average life expectancy in South Africa from 70 years down to 30,...
We are not the problem. (Chief Concern).
Treat-your-workers.org; international Coca-Cola protest October 17.
African AIDS drug compliance report refutes world media.
India to expand its free antiretroviral therapy to cover all with HIV-AIDS.
GREEK MINISTRY APPROVES PRICE INCREASE FOR AMPHOCIL.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles